Production of biosimilars, similar to the original pharmaceuticals that faces certain challenges like possible need for unique naming to differentiate the various biopharmaceutical products, regulatory framework and commercial opportunities have made the researchers in head over heels to design the appropriate one. Clinical applications have to be the main target that relies on cost-effectiveness and market value.
Show abstract
Full Text
